NEVVI Medicare utilization intelligence

← back

Provider profile

ZACHARIS, THEODOSSIS MD

Pulmonary Disease · NPI 1205889243 · NEW SMYRNA BEACH, FL

1
Groups
38
Codes · 2024
59,584
Disclosed services

ZACHARIS, THEODOSSIS is a Pulmonary Disease in NEW SMYRNA BEACH, FL, a member of 1 medical group, who billed 38 distinct codes to Medicare Part B in 2024.

Groups: PCCC OF VOLUSIA LLC (NEW SMYRNA BEACH, FL)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

59,584
disclosed services
38
codes billed to Medicare Part B
Prior year · CY2023 27,020 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1010 Injection, methylprednisolone acetate, 1 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J0696 Injection, ceftriaxone sodium, per 250 mg premiumpremium premiumpremium
94060 Test to measure expiratory airflow and volume changes before and after medication administration premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
J1956 Injection, levofloxacin, 250 mg premiumpremium premiumpremium
94729 Test to examine how well the lungs exchange gases premiumpremium premiumpremium
94726 Test to determine lung volumes using sensors premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
J1335 Injection, ertapenem sodium, 500 mg premiumpremium premiumpremium
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes premiumpremium premiumpremium
J0692 Injection, cefepime hydrochloride, 500 mg premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
94664 Evaluation of use of breathing device premiumpremium premiumpremium
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes premiumpremium premiumpremium
99291 Critical care, first 30-74 minutes premiumpremium premiumpremium
94660 Therapy procedure using a positive pressure ventilator premiumpremium premiumpremium
G0008 Administration of influenza virus vaccine premiumpremium premiumpremium
J1040 Injection, methylprednisolone acetate, 80 mg premiumpremium premiumpremium
95810 Sleep study in sleep lab (6 years or older) premiumpremium premiumpremium
J1940 Injection, furosemide, up to 20 mg premiumpremium premiumpremium
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) premiumpremium premiumpremium
90661 Influenza vaccine, trivalent derived from cell cultures premiumpremium premiumpremium
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes premiumpremium premiumpremium
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and premiumpremium premiumpremium
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation premiumpremium premiumpremium
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
31624 Irrigation and suction of lung airways to obtain cells using an endoscope premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
90653 Influenza vaccine, inactivated premiumpremium premiumpremium
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage premiumpremium premiumpremium
94618 Test for exercise-induced lung stress premiumpremium premiumpremium
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.